Martin J. Madden, Director at NovoCure Ltd (NVCR), sold 999 shares at $17.19 ($17K) on 2025-06-03, disclosed to the SEC on 2025-06-04.
Open-market sale of $17k NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.